As of 2025-07-03, the Intrinsic Value of Akero Therapeutics Inc (AKRO) is -16.90 USD. This AKRO valuation is based on the model Peter Lynch Fair Value. With the current market price of 51.88 USD, the upside of Akero Therapeutics Inc is -132.58%.
Based on its market price of 51.88 USD and our intrinsic valuation, Akero Therapeutics Inc (AKRO) is overvalued by 132.58%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.90 - -16.90 | -16.90 | -132.58% |
| P/E | (59.01) - (81.59) | (72.84) | -240.4% |
| DDM - Stable | (29.85) - (97.36) | (63.60) | -222.6% |
| DDM - Multi | (19.13) - (49.42) | (27.69) | -153.4% |
| Market Cap (mil) | 4,135.87 |
| Beta | 0.67 |
| Outstanding shares (mil) | 79.72 |
| Enterprise Value (mil) | 3,985.43 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.53% |
| Cost of Debt | 5.00% |
| WACC | 9.48% |